The store will not work correctly when cookies are disabled.
ethyl 6-methoxy-4-((2-nitrophenyl)ethynyl)quinoline-2-carboxylate
ID: ALA4648478
PubChem CID: 156021770
Max Phase: Preclinical
Molecular Formula: C21H16N2O5
Molecular Weight: 376.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc(C#Cc2ccccc2[N+](=O)[O-])c2cc(OC)ccc2n1
Standard InChI: InChI=1S/C21H16N2O5/c1-3-28-21(24)19-12-15(17-13-16(27-2)10-11-18(17)22-19)9-8-14-6-4-5-7-20(14)23(25)26/h4-7,10-13H,3H2,1-2H3
Standard InChI Key: KPGQVNQLJZAUSE-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
39.2114 -12.7614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2102 -13.5809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9183 -13.9899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9165 -12.3525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6251 -12.7578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6259 -13.5768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3344 -13.9838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0427 -13.5730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0379 -12.7509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3288 -12.3475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.7431 -12.3380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5022 -13.9889 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.4533 -12.7423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.1585 -12.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.8687 -12.7337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7382 -11.5208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.7948 -13.5798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3361 -14.8010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3301 -15.6174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3240 -16.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6099 -16.8342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6035 -17.6506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3087 -18.0652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0218 -17.6575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0247 -16.8424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7357 -16.4357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.7386 -15.6185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.4420 -16.8468 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
2 12 1 0
11 13 1 0
13 14 1 0
14 15 1 0
11 16 2 0
12 17 1 0
7 18 1 0
18 19 3 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
26 27 2 0
26 28 1 0
25 26 1 0
M CHG 2 26 1 28 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 376.37 | Molecular Weight (Monoisotopic): 376.1059 | AlogP: 3.73 | #Rotatable Bonds: 4 |
Polar Surface Area: 91.56 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.15 | CX LogP: 4.58 | CX LogD: 4.58 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.30 | Np Likeness Score: -0.96 |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |